Variant Phenotype Annotation
证据URL
https://www.pharmgkb.org/variantAnnotation/1183703991
总结
CYP2D6 poor metabolizer is associated with increased risk of Recurrence when treated with tamoxifen in people with Breast Neoplasms as compared to CYP2D6 *1 (assigned as normal metabolizer phenotype) .